NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
BigBear.ai Holdings
BBAI
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
IDYA IDEAYA Biosciences
- 20.570
- +0.330+1.63%
Close Feb 28 16:00 ET
- 20.600
- +0.030+0.15%
Post 20:01 ET
1.80BMarket Cap-6.12P/E (TTM)
20.590High19.950Low1.14MVolume20.200Open20.240Pre Close23.26MTurnover1.32%Turnover RatioLossP/E (Static)87.54MShares47.72052wk High1.70P/B1.78BFloat Cap19.95052wk Low--Dividend TTM86.63MShs Float47.735Historical High--Div YieldTTM3.16%Amplitude2.950Historical Low20.351Avg Price1Lot Size
IDEAYA Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -114.87%-247.58M | -412.27%-121.66M | -63.17%-49.23M | 1.73%-32.88M | -57.36%-43.81M | -32.18%-115.22M | -1.62%-23.75M | -24.86%-30.17M | -67.37%-33.46M | -41.71%-27.84M |
| Net income from continuing operations | -142.98%-274.48M | -283.78%-130.31M | -88.85%-51.82M | -88.97%-52.77M | -67.39%-39.57M | -92.59%-112.96M | -40.30%-33.96M | -1,799.07%-27.44M | -26.61%-27.93M | -68.70%-23.64M |
| Depreciation and amortization | -4.34%3.83M | -37.21%643K | -1.36%1.01M | 9.92%1.1M | 12.71%1.08M | 14.03%4.01M | 11.06%1.02M | 10.92%1.03M | 16.05%998K | 18.81%960K |
| Change In working capital | 187.42%11.55M | -58.30%3.45M | 58.56%-2.28M | 280.26%15.7M | 26.75%-5.32M | 69.26%-13.21M | 526.04%8.26M | 81.45%-5.5M | -333.50%-8.71M | 22.69%-7.26M |
| -Change in receivables | -92.23%15K | -99.75%17K | 99.71%-19K | -95.45%14K | 101.17%3K | -78.36%193K | 106.45%6.69M | -106.99%-6.54M | -24.69%308K | -163.30%-257K |
| -Change in prepaid assets | -201.91%-6.17M | -139.78%-1.74M | -178.69%-934K | 90.44%-371K | -328.19%-3.13M | 3.49%-2.05M | 55.50%-724K | 369.16%1.19M | -760.53%-3.88M | 243.25%1.37M |
| -Change in payables and accrued expense | 346.70%19.07M | 24.23%5.25M | -160.87%-1.04M | 1,438.23%16.59M | -300.46%-1.73M | -33.65%4.27M | 486.94%4.23M | 144.65%1.72M | -130.91%-1.24M | -142.97%-431K |
| -Change in other current liabilities | 26.87%-1.37M | 82.34%-86K | 41.05%-280K | -17.21%-538K | -3.10%-465K | -10.18%-1.87M | -10.18%-487K | -10.21%-475K | -10.07%-459K | -10.27%-451K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | 70.41%-13.75M | 62.41%-1.44M | 94.76%-1.38M | 38.21%-3.44M | 30.55%-7.5M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -114.87%-247.58M | -412.27%-121.66M | -63.17%-49.23M | 1.73%-32.88M | -57.36%-43.81M | -32.18%-115.22M | -1.62%-23.75M | -24.86%-30.17M | -67.37%-33.46M | -41.71%-27.84M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -217.16%-502.56M | -76.08%-197.11M | -139.02%-20.04M | 156.48%68.56M | -1,604.91%-353.97M | -374.36%-158.46M | -989.36%-111.94M | 374.83%51.35M | -1,011.54%-121.38M | 232.43%23.52M |
| Net PPE purchase and sale | -62.88%-3.86M | -31.50%-1.1M | 24.21%-457K | -10.07%-973K | -2,981.40%-1.33M | 31.22%-2.37M | ---838K | 45.23%-603K | 54.46%-884K | 89.28%-43K |
| Net investment purchase and sale | -219.50%-498.7M | -76.42%-196.01M | -137.69%-19.58M | 157.70%69.53M | -1,596.55%-352.65M | -420.97%-156.09M | -981.21%-111.11M | 395.47%51.95M | -889.78%-120.5M | 235.74%23.56M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -217.16%-502.56M | -76.08%-197.11M | -139.02%-20.04M | 156.48%68.56M | -1,604.91%-353.97M | -374.36%-158.46M | -989.36%-111.94M | 374.83%51.35M | -1,011.54%-121.38M | 232.43%23.52M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 86.80%677.55M | -98.05%2.75M | 929.33%286.5M | -79.49%39.18M | 11,831.34%349.11M | 273.30%362.72M | 43,385.80%140.89M | -70.91%27.83M | 38,813.03%191.06M | 348.09%2.93M |
| Net common stock issuance | 111.20%654.23M | -100.32%-405K | 957.25%274.66M | -76.39%36.32M | 13,323.83%343.65M | 226.20%309.76M | 24,937.82%127.42M | -72.81%25.98M | 233,139.39%153.81M | 28,544.44%2.56M |
| Net preferred stock issuance | -77.72%9.4M | ---- | ---- | ---- | ---- | --42.18M | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 29.24%13.92M | 78.26%-6.24M | 538.33%11.84M | -92.32%2.86M | 1,392.08%5.46M | 388.97%10.77M | -3,529.63%-28.71M | 1,161.90%1.86M | 6,588.87%37.26M | -44.71%366K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 86.80%677.55M | -98.05%2.75M | 929.33%286.5M | -79.49%39.18M | 11,831.34%349.11M | 273.30%362.72M | 43,385.80%140.89M | -70.91%27.83M | 38,813.03%191.06M | 348.09%2.93M |
| Net cash flow | ||||||||||
| Beginning cash position | 129.53%157.78M | 162.95%401.19M | 77.63%183.96M | 62.01%109.1M | 129.53%157.78M | -25.41%68.74M | 49.49%152.57M | 110.45%103.57M | 21.56%67.34M | -25.41%68.74M |
| Current changes in cash | -181.53%-72.59M | -6,173.63%-316.01M | 343.27%217.23M | 106.66%74.86M | -3,389.10%-48.67M | 480.27%89.04M | 115.61%5.2M | -7.27%49.01M | 685.64%36.22M | 96.20%-1.4M |
| End cash Position | -46.01%85.18M | -46.01%85.18M | 162.95%401.19M | 77.63%183.96M | 62.01%109.1M | 129.53%157.78M | 129.53%157.78M | 49.49%152.57M | 110.45%103.57M | 21.56%67.34M |
| Free cash flow | -113.82%-251.44M | -399.30%-122.76M | -61.45%-49.69M | 1.42%-33.86M | -61.87%-45.14M | -29.77%-117.59M | -5.20%-24.59M | -21.81%-30.78M | -56.59%-34.34M | -39.09%-27.89M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |